Materials-based drug delivery approaches: Recent advances and future perspectives

Materials-based drug delivery approaches have garnered substantial attention in recent years due to their potential to revolutionize pharmaceutical interventions. This abstract provides a concise overview of recent advancements and future prospects in this rapidly evolving field. Materials such as n...

Full description

Saved in:
Bibliographic Details
Published inGreen processing and synthesis Vol. 13; no. 1; pp. 393 - 410
Main Authors Pei, JinJin, Yan, Yuqiang, Palanisamy, Chella Perumal, Jayaraman, Selvaraj, Natarajan, Prabhu Manickam, Umapathy, Vidhya Rekha, Gopathy, Sridevi, Roy, Jeane Rebecca, Sadagopan, Janaki Coimbatore, Thalamati, Dwarakesh, Mironescu, Monica
Format Journal Article
LanguageEnglish
Published Berlin De Gruyter 21.02.2024
Walter de Gruyter GmbH
Subjects
Customization
Drug delivery
Drug delivery systems
Drug development
External stimuli
nanomaterials
nanomedicine
Nanoparticles
natural products
Patients
Pharmaceuticals
Physiological effects
Polymers
Precision medicine
Smart materials
Online AccessGet full text

Cover

More Information
Summary:Materials-based drug delivery approaches have garnered substantial attention in recent years due to their potential to revolutionize pharmaceutical interventions. This abstract provides a concise overview of recent advancements and future prospects in this rapidly evolving field. Materials such as nanoparticles, liposomes, polymers, and hydrogels have emerged as versatile carriers for drug delivery. These materials facilitate precise control over drug release kinetics, enabling targeted and sustained therapeutic effects. Smart materials with responsiveness to external stimuli or physiological conditions have further enhanced drug delivery precision. Personalized medicine approaches are gaining traction, tailoring drug delivery systems to individual patient profiles and needs. The horizon for materials-based drug delivery is bright. Ongoing research is focused on refining material design, streamlining production processes, and ensuring safety profiles. Collaborative efforts among researchers, clinicians, and industry stakeholders are crucial for translating these advancements into clinical practice. Additionally, the convergence of drug delivery with diagnostics and imaging holds immense potential for personalized and efficient healthcare solutions. As materials-based drug delivery continues to evolve, it stands poised to reshape the landscape of pharmaceuticals, offering the promise of more effective and patient-centered therapies for a wide range of medical conditions.
ISSN:2191-9550
2191-9542
2191-9550
DOI:10.1515/gps-2023-0094